1. Home
  2. Govt releases list of 9500 high-risk financial companies including Adani

Govt releases list of 9500 high-risk financial companies including Adani

Agencies
February 26, 2018

New Delhi, Feb 26: Financial Intelligence Unit of Union government on Monday released a list of around 9,500 Non-Banking Financial Companies (NBFCs), which have been categorised as high-risk financial institutions by the Finance Ministry.

As per the Prevention of Money Laundering Act (PMLA), all NBFCs have to appoint a principal officer in the financial institutions and report all suspicious and cash transactions of over 10 lakh rupees to the FIU.

But, these companies have been found not following these rules as on January 31, 2018.

The FIU released the list on its website showing the names of NBFCs, which have been found non-compliant to the PMLA rules.

ADANI CAPITAL PRIVATE LIMITED, Anand Corporate Holdings Pvt. Ltd., Arihant Udyog Ltd., Asian Financial Services Ltd., AVON MONEY SOLUTION INDIA LIMITED, Bindal Finvest., Bombay Gas Co Ltd., CELLO CAPITAL PRIVATE LIMITED, Dlf Finvest Limited, Eros Merchants (P) Ltd, and Indigo Fincap Pvt Ltd are a few of the companies listed by FIU.

After demonetisation in 2016, NBFCs and several other rural and urban cooperative banks had come under the scanner of the Income Tax Department and the Enforcement Directorate (ED) for illegally converting banned currency notes.

Comments

PK
 - 
Tuesday, 27 Feb 2018

Adani Ready to run out of country... Preparing public that govt has warned before... thats Y name is mentioned.

hardik gala
 - 
Monday, 26 Feb 2018

Where can i get the full 9.5k Companies names?

As because Adani is most favoured child of our government. Truth is always bitter for you and left to you , you would have excluded Adani's name.

Prabhakar Bhatt
 - 
Monday, 26 Feb 2018

why mention only Adani's name, publish the detailed list of all the 9500, high risk NBFC's

Prabhakar Bhatt
 - 
Monday, 26 Feb 2018

why mention only Adani's name, publish the detailed list of all the 9500, high risk NBFC's

Gaurav
 - 
Monday, 26 Feb 2018

If Govt has to release such a list for obevious reasons... clearly Banks are miserably failing to do their job!

Harsha Bopaiah
 - 
Monday, 26 Feb 2018

So what is one expected to do? Take loans from these companies or dont invest in these companies. Should employees of these companies start looking for Jobs?. This is a meaningless exercise just to tell people that we had warned you.

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
June 21,2020

Mangaluru, Jun 21: A total of 51 private hospitals and medical colleges empanelled under the Suvarna Arogya Suraksha Trust (SAST) have been allowed to treat Covid-19 patients in Dakshina Kannada and Udupi district. Among them 30 are in Dakshina Kannada and 21 are in Udupi. Here is the full list:

Also Read: 518 private hospitals across Karnataka can now treat covid patients

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Mangaluru, Apr 4: The chemistry department of National Institute of Technology-Karnataka (NIT-K) here has started producing hand sanitizers in view of its shortage in the market after the coronavirus outbreak.

The social initiative led by Arun Isloor, professor and head of the department, was launched by NIT-K director K Uma Maheshwar Rao.

The raw materials needed for this product were provided by the institute.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.